Characteristics and outcomes of COVID-19 patients during B.1.1.529 (Omicron) dominance compared to B.1.617.2 (Delta) in 89 German hospitals

BACKGROUND: The SARS-CoV-2 variant B.1.1.529 (Omicron) was first described in November 2021 and became the dominant variant worldwide. Existing data suggests a reduced disease severity with Omicron infections in comparison to B.1.617.2 (Delta). Differences in characteristics and in-hospital outcomes...

Descripción completa

Detalles Bibliográficos
Autores principales: Leiner, Johannes, Pellissier, Vincent, Hohenstein, Sven, König, Sebastian, Schuler, Ekkehard, Möller, Robert, Nachtigall, Irit, Bonsignore, Marzia, Hindricks, Gerhard, Kuhlen, Ralf, Bollmann, Andreas
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610359/
https://www.ncbi.nlm.nih.gov/pubmed/36303111
http://dx.doi.org/10.1186/s12879-022-07781-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9610359/
https://www.ncbi.nlm.nih.gov/pubmed/36303111
http://dx.doi.org/10.1186/s12879-022-07781-w

Ejemplares similares